BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37328464)

  • 21. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
    Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
    Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic postconditioning relieves cerebral ischemia and reperfusion injury through activating T-LAK cell-originated protein kinase/protein kinase B pathway in rats.
    Zhao H; Wang R; Tao Z; Gao L; Yan F; Gao Z; Liu X; Ji X; Luo Y
    Stroke; 2014 Aug; 45(8):2417-24. PubMed ID: 25013016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells.
    Kato T; Inoue H; Imoto S; Tamada Y; Miyamoto T; Matsuo Y; Nakamura Y; Park JH
    Oncotarget; 2016 Apr; 7(14):17652-64. PubMed ID: 26933922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of T-LAK cell-originated protein kinase.
    Fan X; Duan Q; Ke C; Zhang G; Xiao J; Wu D; Zeng X; Chen J; Guo J; Zhou J; Shi F; Zhu F
    Oncotarget; 2016 Apr; 7(17):24633-45. PubMed ID: 27016423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.
    Xue P; Wang Y; Zeng F; Xiu R; Chen J; Guo J; Yuan P; Liu L; Xiao J; Lu H; Wu D; Pan H; Lu M; Zhu F; Shi F; Duan Q
    Oncotarget; 2017 Apr; 8(16):27093-27104. PubMed ID: 28404919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity.
    Zykova TA; Zhu F; Vakorina TI; Zhang J; Higgins LA; Urusova DV; Bode AM; Dong Z
    J Biol Chem; 2010 Sep; 285(38):29138-46. PubMed ID: 20647304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis.
    Gao T; Hu Q; Hu X; Lei Q; Feng Z; Yu X; Peng C; Song X; He H; Xu Y; Zuo W; Zeng J; Liu Z; Yu L
    Cancer Lett; 2019 Mar; 445():11-23. PubMed ID: 30590102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of eEF1A1 re-expression on proliferation and apoptosis of Jurkat cells with knocked down eEF1A1 gene and its mechanisms].
    Huang Y; Hu JD; Wu YA; Zheng J; Qi YL; Chen YY; Huang XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):279-84. PubMed ID: 23628016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
    Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
    Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-LAK cell-originated protein kinase is essential for the proliferation of hepatocellular carcinoma SMMC-7721 cells.
    Chen F; Li R; Wang C; Cao L; Wang Y; Yu L
    Cell Biochem Funct; 2013 Dec; 31(8):736-42. PubMed ID: 23526201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of IκBα at serine 32 by T-lymphokine-activated killer cell-originated protein kinase is essential for chemoresistance against doxorubicin in cervical cancer cells.
    Park JH; Yoon DS; Choi HJ; Hahm DH; Oh SM
    J Biol Chem; 2013 Feb; 288(5):3585-93. PubMed ID: 23250755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scutellarin Suppresses RPMI7951 Melanoma Cell Proliferation by Targeting TOPK.
    Mu X; Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S
    Anticancer Agents Med Chem; 2021; 21(5):640-648. PubMed ID: 32781970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN/PI3K/Akt Signaling.
    Gao S; Wang R; Dong S; Wu J; Perek B; Xia Z; Yao S; Wang T
    Oxid Med Cell Longev; 2021; 2021():6657529. PubMed ID: 33986917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase
    Fu X; Zhao R; Yoon G; Shim JH; Choi BY; Yin F; Xu B; Laster KV; Liu K; Dong Z; Lee MH
    Front Cell Dev Biol; 2021; 9():638174. PubMed ID: 33842463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC.
    Xiao J; Zhang L; Yi H; Zou L; Mo J; Xue F; Zheng J; Huang Y; Lu H; Wu H; Xue P; Zhang X; He L; Li Z; Pang S; Qiao G; Duan Q; Zhu F
    Cell Death Dis; 2022 Sep; 13(9):828. PubMed ID: 36167821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation.
    Gao S; Zhu Y; Li H; Xia Z; Wu Q; Yao S; Wang T; Yuan S
    Int Immunopharmacol; 2016 Sep; 38():395-401. PubMed ID: 27355132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.
    Herbert KJ; Ashton TM; Prevo R; Pirovano G; Higgins GS
    Cell Death Dis; 2018 Oct; 9(11):1089. PubMed ID: 30356039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients.
    Fan AH; Zhao X; Liu H; Li D; Guo T; Zhang J; Duan L; Cheng H; Nie Y; Fan D; Zhao X; Lu Y
    Cancer Med; 2023 Jan; 12(1):513-524. PubMed ID: 35607944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.
    Li Y; Yang Z; Li W; Xu S; Wang T; Wang T; Niu M; Zhang S; Jia L; Li S
    Oncotarget; 2016 Feb; 7(6):6748-64. PubMed ID: 26745678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.